Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

2.1K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.1K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

2.3K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.3K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

839
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
839
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

222
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
222
Oral Hypoglycemic Agents: Biguanides and Glitazones01:26

Oral Hypoglycemic Agents: Biguanides and Glitazones

149
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
149
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors01:19

Oral Hypoglycemic Agents: α-Glucosidase Inhibitors

141
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...
141

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Transcutaneous CO<sub>2</sub> Therapy Improves Tissue Oxygenation, Ulcer Healing and Pain in Recurrent Hard-to-Heal Diabetic Foot Ulcers: A Randomized Controlled Trial.

The international journal of lower extremity wounds·2026
Same author

Pacinian Corpuscle Distribution, Density, and Morphology of the Adult Human Foot in Health and Diabetes: A Scoping Review.

The international journal of lower extremity wounds·2026
Same author

New Therapies for Sarcoidosis: Molecular and Pathophysiological Basis.

International journal of molecular sciences·2026
Same author

Multidermatomal Herpes Zoster Involving All Three Branches of the Trigeminal Nerve in an Immunocompetent Adult: A Case Report.

Reports (MDPI)·2026
Same author

Replication Study of ENPP1 Variants and Haplotypes Associated with Severe Obesity in a Greek Adult Population.

Biochemical genetics·2026
Same authorSame journal

Comparative Efficacy of Oral Antidiabetic Drugs on Metabolic Dysfunction-associated Steatotic Liver Disease Progression in Patients with Type 2 Diabetes: A Retrospective Cohort Study.

Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association·2026

Related Experiment Video

Updated: May 23, 2025

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory
10:03

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory

Published on: February 28, 2013

25.7K

Contraception and Diabetes Mellitus.

Theodoros Panou1, Evanthia Gouveri1, Angeliki Gerede2

  • 1Diabetes Centre, Second Department of Internal Medicine, Democritus University of Thrace, University Hospital of Alexandroupolis, Greece.

Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association
|March 18, 2025
PubMed
Summary

Women with diabetes mellitus (DM) often use ineffective contraception and face drug interactions. Safe options like implants and IUDs are available, but novel diabetes drugs may impact oral contraceptive efficacy.

More Related Videos

Live Images of GLUT4 Protein Trafficking in Mouse Primary Hypothalamic Neurons Using Deconvolution Microscopy
08:47

Live Images of GLUT4 Protein Trafficking in Mouse Primary Hypothalamic Neurons Using Deconvolution Microscopy

Published on: December 7, 2017

9.6K
Homogeneous Time-resolved F&#246;rster Resonance Energy Transfer-based Assay for Detection of Insulin Secretion
07:30

Homogeneous Time-resolved Förster Resonance Energy Transfer-based Assay for Detection of Insulin Secretion

Published on: May 10, 2018

9.2K

Related Experiment Videos

Last Updated: May 23, 2025

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory
10:03

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory

Published on: February 28, 2013

25.7K
Live Images of GLUT4 Protein Trafficking in Mouse Primary Hypothalamic Neurons Using Deconvolution Microscopy
08:47

Live Images of GLUT4 Protein Trafficking in Mouse Primary Hypothalamic Neurons Using Deconvolution Microscopy

Published on: December 7, 2017

9.6K
Homogeneous Time-resolved F&#246;rster Resonance Energy Transfer-based Assay for Detection of Insulin Secretion
07:30

Homogeneous Time-resolved Förster Resonance Energy Transfer-based Assay for Detection of Insulin Secretion

Published on: May 10, 2018

9.2K

Area of Science:

  • Endocrinology
  • Reproductive Health
  • Pharmacology

Background:

  • Women with diabetes mellitus (DM) have unique considerations regarding contraception.
  • Limited physician-patient discussions and suboptimal contraceptive method selection are prevalent in this population.
  • Potential drug-drug interactions between antidiabetic medications and hormonal contraceptives pose a significant concern.

Purpose of the Study:

  • To review current data on contraception for women with diabetes mellitus.
  • To highlight challenges in contraceptive counseling and method choice for women with DM.
  • To assess the safety and efficacy of various contraceptive methods in the context of diabetes.

Main Methods:

  • This study is a narrative review of existing literature on contraception in women with diabetes mellitus.
  • Data synthesis focused on contraceptive method effectiveness, safety, and drug interactions.
  • Analysis included information on hormonal contraceptives, implants, intrauterine devices, and progestin-only methods.

Main Results:

  • Approximately 12.5% of women with DM utilize ineffective contraception.
  • Most antidiabetic agents do not interfere with hormonal contraceptives, but novel agents may reduce oral contraceptive efficacy.
  • Implants, intrauterine devices, and progestin-only contraceptives are generally considered safe for women with DM.

Conclusions:

  • Contraceptive counseling and method selection for women with diabetes require careful consideration.
  • Long-acting reversible contraceptives and progestin-only methods are preferred safe options.
  • Further research is needed to clarify the long-term effects of oral contraceptives on diabetic complications and the impact of new antidiabetic drugs on hormonal contraception.